By: I. Ugrasal, M.B. B.CH. B.A.O., M.B.B.Ch., Ph.D.
Associate Professor, Cleveland Clinic Lerner College of Medicine
Photoselective vaporizatin of the prostate using a laser high performance system in the canine model high blood pressure medication and lemon juice order altace 2.5 mg without a prescription. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers hypertension 140 90 buy altace uk. Urolase laser prostatectomy in patients on warfarin anticoagulation: A safe treatment alternative for bladder outlet obstruction blood pressure medication that does not cause weight gain altace 5mg cheap. Management of benign prostatic hyperplasia by transurethral laser ablation in patients treated with warfarin anticoagulation blood pressure medication post stroke order altace 5mg free shipping. A prospective randomized study comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results. This month in investigative urology: Transurethral laser treatment of benign prostatic hyperplasia. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia. Gross Department of Urology, Asklepios Klinik Barmbek, Hamburg, Germany Introduction A good understanding of laser principles is required to choose the appropriate laser for any medical application [1, 2]. Important in this respect is the optimization of the absorption process of light in tissue, as laser radiation is simply directed light of a narrow bandwidth. This is synonymous with a single color and applies for all regions of the invisible and visible electromagnetic spectrum. For surgical applications the most important process in the interaction of light and tissue interaction is absorption. When the laser beam hits tissue, a certain percentage is reflected by the boundary layer. The reflected radiation not only is lost for the surgical purpose but this laser energy, in the form of heat, may be a risk to surrounding tissue. Reflection depends on the optical properties of the tissue and the irrigant surrounding it, but is not very dependent on wavelength and therefore may be neglected when evaluating a laser wavelength for a surgical purpose. Since tissue is not homogenous, part of the incident laser beam is scattered, taking the applied laser beam out of its intended direction. The degree of scattering depends on the size of the particles that the laser beam encounters and on the wavelength of the laser. Shorter wavelengths are scattered to a much higher degree than longer wavelengths. Blue laser radiation is scattered more than green, green more than red, and red more than infrared. This scattered fraction of laser energy is not only lost for the intended purpose but may also cause unintended side effects. Useful body chromophores for surgical proce- dures are melanin, blood, and water, although melanin has no use in urologic applications. The absorption length defines the optical pathway along which 63% of the incident laser energy is absorbed. Another concept, the extinction length, defines the depth at which 90% of the incident laser beam will have been absorbed and converted into heat. Absorbed laser energy is converted into heat and causes an increase in temperature. Depending on the density of absorbed heat, the impact on tissue may vary between coagulation and vaporization. The temperature in tissue increases with the density of heat per volume of tissue. The higher the absorption by a tissue is, the less heat is generated in its deeper layers. The understanding of this principle is important for any surgical laser application. A Pulsed and continuous wave lasers Lasers can be divided in two major groups, pulsed lasers and continuous wave (cw) lasers. Pulsed holmium lasers create large pulsating steam bubbles in the irrigant surrounding the tip of the laser fiber, whereas those bubbles are much smaller for cw-mode lasers (Figure 129. For the holmium laser, the lifetime of a steam bubble corresponds to the duration of the laser pulse (500 s), which is too short to be visible in video transmission during endoscopic procedures. Subsequently, laser treatment of the prostate has evolved as the main field for application of thulium lasers (Figure 129. Accuracy, energy efficiency, and minimal collateral damage are all found with the cw-mode as opposed to the pulsed mode of the holmium laser. El-Sherif and King tested the ablation abilities of thulium fiber lasers on various soft tissues in vitro, such as muscle, cartilage, and liver [5]. The focus of his interest was measurement of the rate of tissue vaporization in a given time. Thulium laser settings at 26 W, however, were not powerful enough to make efficient and accurate incision [7, 8]. Fried stated that a higher power laser could be used to deliver more energy during a shorter pulse duration, with the intention to reduce the collateral tissue damage.
Laparoscopic renal tumor cryoablation: appropriate application of real-time ultrasonographic monitoring heart attack 64 lyrics quality altace 2.5 mg. Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation heart attack during sex best altace 10mg. Protecting the ureter during radiofrequency ablation of renal cell 1370 Section 7 Image-Guided Diagnostics and Therapeutics: Upper Tract and laparoscopic cryoablation for the treatment of solid renal masses hypertension with bradycardia altace 2.5mg online. Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center pulse pressure nursing buy altace 2.5 mg without prescription. Successful conservative management of colorenal fistula after percutaneous cryoablation of renal-cell carcinoma. Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model. Stereotactic percutaneous cryoablation for renal tumors: initial clinical experience. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. Prophylactic gelatin sponge tract injection to prevent bleeding after percutaneous renal cryoablation in a swine model. Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. Percutaneous cryoablation of renal masses >3 cm: efficacy and safety in treatment of 108 patients. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. In 2008, it was estimated that over 186 000 men would be diagnosed with prostate cancer, with only 10% of these men being diagnosed with high-risk prostate cancer [1, 2]. This shift toward low-risk disease, as well as younger age at the time of diagnosis, not only improves the potential outcomes of treatment, but also emphasizes the need to discuss treatment options within the context of quality-of-life outcomes. Long-term results have shown that oncologic control or "cure" is attainable with definitive treatment in a high percentage of cases. Interest in brachytherapy re-emerged in the 1970s when Whitmore and associates at Memorial Sloan Kettering in New York established an open, retropubic approach using iodine125 seeds [9]. However, trying to uniformly implant the exposed gland did not prove to be the best way to achieve homogenous dose coverage. The 15-year outcomes were disappointing, with only 21% of patients reported to be controlled. A resurgence of prostate brachytherapy occurred in the 1980s due to the transperineal approach developed by Holm et al. The approach adopted in Seattle utilized a "pre-plan" to account for the seed placement, while in New York a more conservative approach was developed to limit the morbidity of the procedure by peripherally placing seeds to limit central hot spots [11]. Patient selection Implantation of the prostate is an attractive option because it concentrates treatment on the prostate and minimizes radiation exposure and morbidity to nearby organs, including the bladder, rectum, and small bowel. The implant serves as the delivery mode of the isotopes, which decay over time and represent the actual treatment. History of prostate brachytherapy Prostate brachytherapy predates radical prostatectomy, having been introduced in the 1920s with radium needle implants. Later, in the 1960s, radioactive gold seeds were used to treat prostate cancer [8]. Accurate placement of the needles is achieved with this technique and the isotopes are placed through them into the prostate. Several approaches are used for seed implant, but the key to success is more the implant quality than the technique. One approach calls for linked or stranded seeds to be placed based on a "pre-plan" of the implant. One advantage of this technique is that the seeds cannot migrate from the prostate. Another approach is a realtime, adaptive implant, using an interstitial gun to place each seed. Using intraoperative software, a "forward" plan can be generated based on the exact prostate volume and location. Also, with dynamic and adaptive assessment, fewer sources can be used while maintaining a high quality implant. Use of fewer seeds offers an opportunity for reducing both the rectal and urethral doses while still achieving adequate prostate coverage. Given its shorter half-life, it was postulated that 103Pd would become the preferred isotope for tumors of higher Gleason score, because of their faster tumor doubling time [21]. Nevertheless, there have been no data to date to suggest that isotope choice should be based on tumor grade or prostate cancer doubling time. Higher rates of acute urinary obstruction date back to older techniques that failed to spare high doses centrally within the prostate. While it is customary to offer men with enlarged prostates a 3-month course of androgen ablation to reduce the prostate volume, there are data from Crook et al. Further, the long-term impact on potency of even a 3-month course of androgen ablative therapy needs to be considered. At present, an age-related bias exists within the urologic community, with younger patients being referred more often for radical prostatectomy than either radiation or no therapy.
